TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

25.70$ +4.8% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow BEAM
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – -762.3% – –
– +5,809.1% +438.9% +35.2% +57.4% +89.9% +41.5% +9.6% +1.7%
– +3,436.4% +0.4% +118.8% +183.3% +93.5% +17.0% +22.3% -21.9%
– – -83.9% +556.3% +109.2% -90.9% – – –
– +1,261.5% -206.3% – +1,980.7% +126.2% -146.3% – –
– +3,693.1% -4.6% +30.7% +186.2% +4.6% -31.1% -73.5% +67.1%
– +3,779.8% +396.6% +50.2% +193.8% +56.8% – +157.5% -165.6%
– – – – – – – – –
– – – – – – – – –
– – +0.0% -70.3% -224.7% +8.0% -1.5% -78.5% -100.0%
– +3,506.1% -77.0% +680.8% +134.6% -85.2% +147.7% -97.2% +6,079.5%
– +7,461.1% -166.7% – +212.9% -182.7% – -177.6% –
– – – – – – – – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?